Skip to content

T Cell Profiling in Patients With Multiple Sclerosis

T Cell Profiling in Patients With Multiple Sclerosis

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04789551
Enrollment
0
Registered
2021-03-09
Start date
2025-12-01
Completion date
2026-12-01
Last updated
2026-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Brief summary

The goal of this research study is to to learn more about the body's immune response in patients with multiple sclerosis (MS). In MS, the body's immune cells mistakenly attack an important part of the nerves of the brain and spinal cord. The immune cells responsible for attacking the nerves in MS patients is primarily the T cells. A marker was recently discovered that might specifically identify these damaging T cells from all other T cells in the body. Understanding which T cells cause the damage in MS patients and understanding more about these specific T cells may help doctors better understand how MS occurs and could possibly prevent MS in the future.

Interventions

OTHERBlood Sample

a blood sample will be collected

Sponsors

Boston Children's Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
13 Years to 20 Years
Healthy volunteers
No

Inclusion criteria

MS Group Inclusion criteria -diagnosis of multiple sclerosis and present to the neurology clinic for a regular checkup or are admitted to the inpatient floor with acute symptoms.

Exclusion criteria

* Have an active infection * Take T cell modulating drugs Control Group Inclusion criteria -scheduled for elective surgery * without any immunological diseases.

Design outcomes

Primary

MeasureTime frameDescription
T cell populationsup to one weekcompare T cell populations between patients with Multiple Sclerosis and healthy controls

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 3, 2026